The legal library gives you easy access to the FTC’s case information and other official legal, policy, and guidance documents.
20170698: TIDI Products Holdings, LLC; Ernest M. Posey
FTC Staff Comment to the National Telecommunications and Information Administration Regarding the Safety Working Groups “Coordinated Vulnerability Disclosure ‘Early Stage’ Template”
Consumer Complaints re Amazon approx. June 2016 through October 2016
PHLG Enterprises LLC
Prepared Statement of the Federal Trade Commission on Stopping Senior Scams: Developments in Financial Fraud Affecting Seniors, Before the Special Committee on Aging, United States Senate
Consumer Complaints re Amazon January 1, 2016 through approximately June 3, 2016
Capitol Network Distance Learning Programs, LLC
20170593: Hewlett Packard Enterprise Company; SimpliVity Corporation
20170662: Stichting Administratiekantoor Lauwerecht; Hi-Pro Feeds L.P.
Stepping Stonez Development, LLC
1702003 Informal Interpretation
1702002 Informal Interpretation
Privacy Act of 1974; System of Records; Proposed Routine Use; Request for Public Comment Concerning FTC Proposal to Permit Disclosure of FOIA Request and Appeal Records to the Office of Government Information Services
iSpring Water Systems, LLC.; Analysis of Proposed Consent Order to Aid Public Comment; Proposed Consent Agreement
Valeant Pharmaceuticals International, Inc., In the Matter of
Valeant Pharmaceuticals, the parent of Bausch + Lomb, agreed to sell Paragon Holdings I, Inc. to settle charges that its May 2015 acquisition of Paragon reduced competition for the sale of FDA-approved buttons used for three types of gas permeable, or GP, lenses: orthokeratology lenses, worn to reshape the cornea; large-diameter scleral lenses, which cover the white of the eye and are used after eye surgery, for corneal transplants, and to treat eye disease; and general vision correction lenses. Valeant will sell Paragon in its entirety to a newly created entity, Paragon Companies LLC, headed by the former president of Paragon, Joe Sicari. Under the settlement, Paragon Companies also will acquire the assets of Pelican Products LLC – a contact lens packaging company that Valeant acquired after its purchase of Paragon – that is the only producer of FDA-approved vials used for shipping some GP lenses.